Atezolizumab,vinorelbine
roche
['nsclc', 'thanks', 'sclc', 'atezo']
today i am vincente. . no problem. my pleasure in any case. ipsos is the first study to show that 1l atezolizumab improves os in this poor-prognosis nsclc population. many clinical implications in our daily practice. very proud. thanks the patients and their families 
Medical Oncologist. Lung Cancer specialist. Born in Salamanca. Director de la Estrategia de Cáncer en Andalucía. Opiniones personales #pandemiacáncer